Predictors of Ovarian Cancer and Endometrial Cancer for Artificial-Intelligence-Based Screening Tools
Launched by HASANUDDIN UNIVERSITY · Jan 14, 2023
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding ovarian and endometrial cancers, which are types of cancers affecting women’s reproductive organs. Researchers aim to identify factors that might help predict the risk of developing these cancers in women in Indonesia. They are developing special screening tools powered by artificial intelligence to improve early detection and diagnosis of these conditions. The study will collect information from women who have been diagnosed with these cancers to find patterns that could help with future screenings.
To be eligible for this study, women must experience certain gynecological symptoms, such as irregular or heavy menstruation, pelvic pain, unusual vaginal discharge, sudden weight loss, or pain during sexual intercourse. They should also have had a routine gynecological examination. Participants in the study can expect to provide valuable information that could lead to better screening methods for ovarian and endometrial cancers, potentially improving outcomes for many women in the future. The study is currently recruiting participants, and it’s an important opportunity for those who meet the criteria to contribute to cancer research.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Women with gynaecological symptoms but not limited to
- • 1. Irregular menstruation
- • 2. Heavy bleeding during menstruation
- • 3. pelvic pain
- • 4. vaginal discharge
- • 5. sudden weight loss
- • 6. pain during sexual intercourse
- • Women who underwent routine gynaecological examination
- Exclusion Criteria:
- • unable to undergo serial gynaecological follow-up
About Hasanuddin University
Hasanuddin University is a prestigious academic institution based in Indonesia, dedicated to advancing healthcare research and education. As a clinical trial sponsor, the university leverages its extensive expertise in medical and health sciences to conduct innovative research aimed at improving patient outcomes and addressing public health challenges. With a commitment to ethical research practices and collaboration with local and international partners, Hasanuddin University plays a vital role in contributing to the body of knowledge in clinical sciences, fostering advancements in treatment methodologies, and enhancing healthcare delivery in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Makassar, South Sulawesi, Indonesia
Makassar, South Sulawesi, Indonesia
Patients applied
Trial Officials
Rina Masadah, Ph.D
Study Chair
Hasanuddin University
Bumi Herman, Ph.D
Principal Investigator
Chulalongkorn University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials